-
1Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trialby Suma Babu, Baileigh G. Hightower, James Chan, Nicole R. Zürcher, Pia Kivisäkk, Chieh-En J. Tseng, Danica L. Sanders, Ashley Robichaud, Haruhiko Banno, Armineuza Evora, Akshata Ashokkumar, Lindsay Pothier, Sabrina Paganoni, Sheena Chew, Joanna Dojillo, Kazuko Matsuda, Mark Gudesblatt, James D. Berry, Merit E. Cudkowicz, Jacob M Hooker, Nazem AtassiGet full text
Published 2021-01-01
Article -
2by Tyler J. Alban, Tyler J. Alban, Defne Bayik, Defne Bayik, Balint Otvos, Balint Otvos, Anja Rabljenovic, Lin Leng, Leu Jia-Shiun, Gustavo Roversi, Adam Lauko, Arbaz A. Momin, Alireza M. Mohammadi, David M. Peereboom, David M. Peereboom, Manmeet S. Ahluwalia, Manmeet S. Ahluwalia, Kazuko Matsuda, Kyuson Yun, Kyuson Yun, Richard Bucala, Michael A. Vogelbaum, Justin D. Lathia, Justin D. Lathia, Justin D. LathiaGet full text
Published 2020-06-01
Article